Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Author:
Publisher
Informa UK Limited
Subject
Neurology (clinical)
Link
http://www.tandfonline.com/doi/pdf/10.1080/14660820310002601
Reference28 articles.
1. Relationship of the Tufts Quantitative Neuromuscular Exam (TQNE) and the Sickness Impact Profile (SIP) in measuring progression of ALS
2. Therapeutic horizons for amyotrophic lateral sclerosis
3. Riluzole for the Treatment of Amyotrophic Lateral Sclerosis -- Too Soon to Tell?
Cited by 112 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Mitochondrial Dysfunction in Sporadic Amyotrophic Lateral Sclerosis Patients: Insights from High-Resolution Respirometry;Biomedicines;2024-06-11
2. Treating amyotrophic lateral sclerosis with allogeneic Schwann cell–derived exosomal vesicles: a case report;Neural Regeneration Research;2024-04-03
3. Accelerating drug development for amyotrophic lateral sclerosis: construction and application of a disease course model using historical placebo group data;Orphanet Journal of Rare Diseases;2024-02-02
4. Alginate Nanofiber Scaffolds for Amyotrophic Lateral Sclerosis;Stem Cell Biology and Regenerative Medicine;2024
5. Fighting against amyotrophic lateral sclerosis (ALS) with flavonoids: a computational approach to inhibit superoxide dismutase (SOD1) mutant aggregation;Journal of Biomolecular Structure and Dynamics;2023-11-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3